… 179 cases of high-risk AML patients under 18 years of age … data of AML patients at first
complete remission (CR1) before … SCT for adult AML patients in their first complete remission (CR1…

… -leukemia (GVL) of haploidentical donor (HID) compared with … acute myeloid leukemia
(H-AML) in first complete remission (… H-AML in CR1 were enrolled in this multicentre prospective …

… with high-risk features, haplo-identical-hematopoietic stem cell transplantation (HID-HSCT) …
an identical sibling donor (ISD-HSCT). However, it is unclear whether an HID-HSC transplant …

… This study was a retrospective, multicenter analysis. Data were provided by the EBMT … an
option for those without a matched identical sibling. The use of nongenoidentical family donors …

… In patients lacking an HLA-identical sibling donor the next … This was a retrospective,
multicenter analysis using the … with ALL in the first or second complete remission (CR1 or CR2, …

… and intermediate risk AML in first complete remission (CR1) [3]… donors other than an
HLA-identical sibling donor [48], studies … Future research should be considered multicenter design …

… We analyzed patients who received allo-SCT from MSD, MUD, and Haplo for acute myeloid
leukemia (AML) in first complete remission (CR1) and reported to the European Society for …

… acute myeloid leukemia (AML). The first included patients with AML in first complete remission
… as the first option for patients lacking an HLA-identical sibling [26,27]. Although GVHD …

… used haploidentical SCT (HIDT), HLA-identical sibling … age 3–65 years and ALL in complete
remission (CR) with pre-HSCT … More multi-center, prospective trials and mechanism studies …

… haploidentical HCT as a reasonable alternative to traditional MSD and MUD allo-HCT for
acute myeloid leukemia (AML) … of haploidentical HCT for ALL in first or subsequent remissions. …